If you or a loved one has been affected by medication error in New York, our experienced New York medication error lawyer team can help. MDLaw Firm has recovered millions for victims of medical negligence across all five boroughs — call 347-524-5777 for a free consultation.
Table of Contents
- How IV Infusion Pumps Work
- Types of Infusion Pump Errors
- Smart Pumps and Dose Error Reduction Systems (DERS)
- High-Alert Medications Commonly Involved
- Standard of Care for IV Infusion Pump Use
- Proving Negligence in Infusion Pump Cases
- Manufacturer Liability and FDA Recalls
- Damages in Infusion Pump Error Cases
- Frequently Asked Questions
How IV Infusion Pumps Work
IV infusion pumps are medical devices that deliver fluids, medications, and nutrients into a patient's circulatory system in controlled amounts. Unlike gravity-fed IV drips, which rely on manual flow-rate adjustments, infusion pumps use electromechanical mechanisms — typically peristaltic pumps or piston-driven syringes — to deliver precise volumes over specific time periods.
Modern "smart pumps" incorporate software with drug libraries, hard and soft dose limits, and clinical decision support. When programmed correctly, a smart pump can prevent the vast majority of dosing errors. When programmed incorrectly — or when safety features are bypassed — the pump becomes an instrument of harm, delivering lethal doses at rates no human could match.
The basic components of an infusion pump system include:
- The pump hardware — The physical device that mechanically delivers the fluid
- The drug library — A software database of medications with pre-configured concentration standards, dosing units, and hard/soft limits
- The DERS (Dose Error Reduction System) — Software that alerts the user when programmed parameters exceed established safety thresholds
- The administration set — The disposable tubing that connects the medication bag to the patient
[Link to: /medical-malpractice/medication-errors]
Types of Infusion Pump Errors
Infusion pump errors fall into several categories, each with distinct legal implications:
Programming Errors
The most common type of infusion pump error is a programming mistake — entering the wrong rate, wrong concentration, wrong dose, or wrong weight into the pump. For example:
- Decimal point errors — Programming 100 mL/hr instead of 10 mL/hr delivers ten times the intended dose
- Unit confusion — Programming in mL/hr when the order was in mg/kg/hr
- Wrong concentration — Failing to update the drug library concentration when the pharmacy changes the standard concentration
- Weight-based dosing errors — Entering the wrong patient weight, which is particularly dangerous for pediatric patients
Mechanical Failures
Mechanical failures occur when the pump hardware malfunctions. These include:
- Flow rate inaccuracies — The pump delivers fluid at a rate different from what was programmed
- Occlusion alarms — The pump fails to detect a blocked line, leading to under-delivery or, when the occlusion clears, a bolus delivery
- Free-flow events — Fluid flows freely without pump control, potentially delivering a large bolus
- Battery failures — The pump stops during a power outage or transport
Software Failures
Software failures in smart pumps can be particularly insidious because they may not trigger any alarm:
- Drug library not updated — The pump uses outdated dosing limits that do not reflect current safety standards
- DERS bypassed — The nurse overrides or disables the dose error reduction system, removing the safety net
- Software bugs — Firmware defects that cause incorrect flow rates or alarm failures
User Workaround Errors
Perhaps the most legally significant category is "user workarounds" — situations where healthcare providers intentionally bypass safety features:
- Silencing alarms — Disabling or ignoring occlusion, air-in-line, or completion alarms
- Using basic mode — Running the pump in basic (non-smart) mode to avoid DERS prompts
- Auto-programming overrides — Accepting auto-programmed values without verification
[Image: IV infusion pump with dose error reduction system interface]
Smart Pumps and Dose Error Reduction Systems (DERS)
The transition from basic infusion pumps to smart pumps with DERS has been one of the most significant patient safety advances in the past two decades. However, the technology is only effective when used correctly.
How DERS Works
When a nurse selects a medication from the pump's drug library, the DERS software loads pre-configured dosing parameters. If the nurse enters a rate or dose that exceeds the soft limit (a threshold that triggers a warning but allows override) or the hard limit (a threshold that cannot be overridden), the pump alerts the user.
The Override Problem
Studies consistently show that override rates for soft-limit alerts range from 30% to 80% in many hospitals. When nurses become desensitized to alerts — a phenomenon known as "alert fatigue" — they routinely override DERS warnings without clinical justification. This effectively disables the safety system and returns the pump to basic mode functionality.
Drug Library Compliance
The effectiveness of smart pumps depends on the drug library being:
- Current — Updated with the latest medications and concentrations
- Complete — Containing all medications used in the facility
- Appropriate — Dosing limits reflecting the patient population (adult, pediatric, ICU, etc.)
When the drug library is outdated or incomplete, nurses may run the pump in basic mode, bypassing DERS entirely. In New York malpractice cases, the failure to maintain an updated drug library can be evidence of institutional negligence.
High-Alert Medications Commonly Involved
The Institute for Safe Medication Practices (ISMP) maintains a list of high-alert medications — drugs that bear a heightened risk of causing significant patient harm when used in error. The medications most frequently involved in infusion pump errors include:
| Medication | Common Error | Potential Consequence | |---|---|---| | Insulin | Programming error (10x overdose) | Severe hypoglycemia, brain damage, death | | Heparin | Rate error, wrong concentration | Life-threatening hemorrhage or thrombosis | | Opioids (morphine, hydromorphone, fentanyl) | Over-infusion, PCA programming error | Respiratory depression, respiratory arrest | | Vasoactive drugs (norepinephrine, epinephrine) | Concentration or rate error | Hypertensive crisis, cardiac arrhythmia | | Potassium chloride | Wrong concentration, too-rapid infusion | Cardiac arrest | | Magnesium sulfate | Programming error in obstetric units | Maternal respiratory depression, fetal harm | | Chemotherapy agents | Wrong rate or concentration | Severe toxicity, tissue necrosis |
[Link to: /medical-malpractice/medication-errors/potassium-chloride-overdose]
Standard of Care for IV Infusion Pump Use
New York hospitals and healthcare providers are expected to follow established standards for infusion pump use. The relevant standards come from multiple sources:
- ISMP Guidelines — The ISMP publishes best practices for smart pump implementation, including drug library management, DERS compliance rates, and independent double checks for high-alert medications
- The Joint Commission Standards — The Joint Commission requires hospitals to have processes for managing infusion pump safety, including drug library updates and compliance monitoring
- New York State Department of Health — Under PHL § 2805-j and 10 NYCRR § 405, hospitals must implement patient safety programs that address medication safety
- ANA (American Nurses Association) Standards — The ANA establishes standards for nursing practice, including medication administration and technology use
Key Standard of Care Elements
- Drug library must be current and complete — Updated regularly to reflect current formulary and safety standards
- DERS must be active — Pumps should be run in smart mode whenever a drug library entry exists
- Independent double checks — Required for high-alert IV medications, including insulin, heparin, and opioids
- Barcode verification — Scanning the patient and medication before pump programming
- Alarm management — Alarms must not be silenced without clinical assessment
- Documentation — Pump programming, rate changes, and alarm events must be documented in the MAR
Proving Negligence in Infusion Pump Cases
Proving negligence in an IV infusion pump case requires a thorough investigation of the pump data, clinical records, and institutional policies.
Pump Data Logs
Modern smart pumps store detailed programming data, including:
- Date and time of programming
- Drug library entry used
- Programmed rate, dose, and concentration
- DERS alerts generated and whether they were overridden
- Actual volume delivered
- Alarm events and nurse responses
This data is typically retrievable from the pump's internal memory or from the hospital's biomedical engineering department. In New York, hospital policies under PHL § 2805-j require preservation of patient safety event data. A litigation hold letter should be sent immediately to prevent data destruction.
Medical Record Review
The medical record must be reviewed for:
- The original medication order and its appropriateness
- The pump programming (documented in the MAR or flowsheet)
- The patient's clinical response (vital signs, lab values, clinical status changes)
- The timing of interventions when the error was recognized
Expert Testimony
Infusion pump cases typically require multiple experts:
- A nursing expert to testify about the standard of care for pump programming and monitoring
- A pharmacy expert to testify about drug library management and high-alert medication protocols
- A biomedical engineer (in cases involving hardware or software failure) to testify about device malfunction
- A physician expert to testify about the medical consequences of the error
Establishing Breach
Breach of the standard of care in infusion pump cases is often established by showing:
- The pump was run in basic mode when a drug library entry was available
- DERS alerts were overridden without clinical justification
- An independent double check was not performed for a high-alert medication
- The drug library was outdated or missing the medication being infused
- Alarms were silenced or ignored
Manufacturer Liability and FDA Recalls
In some cases, the infusion pump itself is defective. The FDA has issued numerous recalls for infusion pumps over the past two decades, affecting major manufacturers including:
- Baxter International — Multiple Colleague pump recalls for software defects, battery failures, and flow rate inaccuracies
- Becton Dickinson (BD/Alaris) — Recalls for software defects, including failures in the DERS module
- B. Braun — Recalls for Infusomat and Perfusor pumps for software and mechanical issues
- Hospira/Pfizer — Recalls for LifeCare PCA pumps for software defects and false alarms
When a pump defect contributes to a medication error, the patient may have a products liability claim against the manufacturer in addition to a medical malpractice claim against the hospital and providers. New York's products liability law allows recovery under theories of:
- Design defect — The pump was inherently dangerous due to its design
- Manufacturing defect — The specific pump was defective due to a manufacturing error
- Failure to warn — The manufacturer failed to adequately warn of known risks
[Link to: /medical-malpractice/medication-errors/automated-dispensing-cabinets]
Damages in Infusion Pump Error Cases
New York does not cap medical malpractice damages. Compensation may include:
- Medical expenses — Past and future costs of treating injuries caused by the infusion pump error, including rehabilitation, long-term care, and ongoing medical needs
- Lost earnings — Past and future lost wages and diminished earning capacity
- Pain and suffering — Physical pain, emotional distress, and loss of enjoyment of life
- Loss of consortium — For the patient's spouse
- Wrongful death damages — Under EPTL § 5-4.1, including pecuniary loss and loss of parental guidance
Statute of Limitations
Under CPLR § 214-a, the statute of limitations for medical malpractice is two years and six months. For products liability claims against pump manufacturers, the statute of limitations under CPLR § 214 is three years from the date of injury.
For municipal hospitals (NYC Health + Hospitals), a Notice of Claim must be filed within 90 days under General Municipal Law § 50-e, and the statute of limitations is one year and 90 days under General Municipal Law § 50-i.
Frequently Asked Questions
What is a smart IV pump?
A smart IV pump is an infusion pump equipped with a Dose Error Reduction System (DERS) — software that checks programmed doses against a drug library of safety limits and alerts the user when parameters exceed safe thresholds. Smart pumps are significantly safer than basic pumps when used correctly, but their effectiveness depends on proper drug library management and DERS compliance.
How common are IV infusion pump errors?
Infusion pump errors are among the most frequently reported medication errors. Studies suggest that programming errors occur in approximately 1-2% of all infusions, but the rate is much higher for high-alert medications. The FDA receives thousands of adverse event reports related to infusion pumps annually.
Can I sue the pump manufacturer?
Yes. If the pump was defective due to a design flaw, manufacturing defect, or software bug, you may have a products liability claim against the manufacturer. This is separate from a medical malpractice claim against the hospital and providers. New York allows both claims to proceed simultaneously.
What is DERS bypass?
DERS bypass occurs when a healthcare provider disables, overrides, or circumvents the Dose Error Reduction System on a smart pump. This can happen by running the pump in basic mode, overriding soft-limit alerts without clinical justification, or using an outdated drug library. DERS bypass is a common factor in infusion pump malpractice cases.
What is an independent double check?
An independent double check is a process where two qualified healthcare professionals independently verify the medication, dose, concentration, pump programming, and patient identity before initiating a high-alert infusion. The ISMP recommends independent double checks for medications like insulin, heparin, and opioids. Failure to perform an independent double check can be evidence of negligence.
How is pump data preserved for my case?
Modern smart pumps store programming data, alarm events, and delivery logs in internal memory. Your attorney should send a litigation hold letter to the hospital immediately, requesting preservation of pump data, drug library configurations, biomedical engineering records, and all relevant clinical documentation. Under New York law, hospitals have a duty to preserve patient safety event data.
What should I do if I suspect an infusion pump error caused my injury?
Request your complete medical records immediately, including medication administration records, pump programming logs, vital sign flowsheets, and laboratory results. Contact a New York medication error attorney who can evaluate your case, engage qualified experts, and send a litigation hold letter to preserve evidence. Do not delay — the statute of limitations may be as short as one year and 90 days for municipal hospitals.
This article is for informational purposes only and does not constitute legal advice. Prior results do not guarantee a similar outcome. No attorney-client relationship is created by reading this article or contacting MDLaw Firm.
If you or a loved one suffered from a medication error, contact our Medication Error lawyers today for a free, confidential consultation. Call 347-524-5777 or request a case review online.